Wellbeing After Stroke (WAterS): Supporting Adjustment and Wellbeing After Stroke

Stroke Clinical Trial

— WAterS  

Official title:

Wellbeing After Stroke (WAterS) Pilot Study Exploring Upskilling a Workforce to Deliver Acceptance and Commitment Therapy (ACT) for Improving Psychological Adjustment and Wellbeing for Groups of Community-based Stroke Survivors

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04655937
• Other study ID #: IRAS ID: 287785
• Status: Completed
• Phase: Phase 1
• Start date: January 5, 2021
• Est. completion date: May 1, 2023

Study information

• Verified date: May 2024
• Source: University of Manchester
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Stroke survivors face a range of mental health challenges adjusting post-stroke. There is a lack of treatment options and clinical psychologist workforce to deliver support. Acceptance and Commitment Therapy (ACT) has been used successfully in clinical services to improve wellbeing.

The investigators worked with stroke survivors, health care professionals and researchers to co-develop group ACT therapy, specifically for stroke survivors, to be delivered using video calling (Zoom). Staff training and supervision programmes were also developed to equip Stroke Association workforce (paraprofessionals) to deliver ACT.

The current study will recruit and train up to 10 professionals with some experience of supporting stroke survivors but no experience of ACT.

We then aim to recruit up to 30 stroke survivors in the community who are at least 4 months post-stroke and experiencing distress adjusting to their stroke. The investigators aimed to make everything accessible for people with mild/moderate difficulties with thinking and communicating. Recruitment took place across England, over a 6 month period.

The study will test how feasible and acceptable it is to deliver the co-developed, remote ACT intervention to stroke survivors, as well as the feasibility of collecting outcomes data:

1. Participants will be invited to consent to complete online measures of well-being every 3 months for up to 12 months (taking around 20 minutes), with the option to participate in group intervention. Those who don't opt for groups will not be treated but will be followed up about their wellbeing, if they agree.

2. Those who opt to attend groups will be randomly assigned into intervention groups A, B, or C and receive the ACT intervention, involving 9 weekly sessions and homework.

Data will be collected on how successfully the groups are delivered and how acceptable they are / how to improve them, through online surveys, feedback questionnaires and interviews.

UPDATE May 2023: The investigators had initially intended to run an active comparator arm of social support and randomly allocated people to arms *and* groups. However, the design changed after the COVID-19 pandemic, meaning that the planning phases took longer than expected in order to pivot all study components to be deliverable online.

*Please see references section for our findings and publications

Description:

UPDATE May 2023: The design changed after the COVID-19 pandemic meant that the planning phases took longer than expected in order to pivot all study components to be deliverable online. Changes are outlined below but to summarise: The study became an observational proof of principle feasibility study with no randomised attention control comparator arm, as was originally planned.

*Please see references section for our findings and publications

Background: Stroke survivors face a range of mental health challenges during the adjustment process post-stroke. It is not always easy for stroke survivors to access treatment to help them face these challenges, due to the lack of interventions and access to clinical psychologists. Acceptance and Commitment Therapy (ACT) has good theoretical underpinning to support adjustment post stroke. The potential benefits of ACT may be further increased by group delivery.

The investigators have worked with stroke survivors, expert clinicians and researchers to develop an ACT intervention to be delivered remotely to groups, to support their adjustment and wellbeing post-stroke. The investigators have also developed a remote staff training and clinical supervision programme to equip professionals with no prior experience of ACT (Stroke Association coordinators) to deliver the intervention (typically an ACT intervention would be delivered by Clinical Psychologists).

Aims: The study aims to explore feasibility and acceptability of trained professionals delivering the adapted ACT intervention to stroke survivors in community settings in the context of a pilot study, with a potential no-treatment group (follow up only).

Methods: There are three work packages described that, whilst distinct, do overlap in terms of participants and timelines. All methods and study materials have been informed through collaboration with stroke survivors and carers through the WAterS Patient and Carer Public Involvement (PCPI) Research User Group (RUG):

• Work package 1 (staff training): remotely training paraprofessionals to deliver the remote ACT intervention. Through qualitative research and competency exercises, explore whether this equips staff with confidence and skills to deliver the study components.

• Work package 2 (pilot study): explore the acceptability of outcomes data collection separate to the acceptability of delivering remote group intervention and other study components. Eligible stroke survivors are recruited with baseline clinical and demographic information collected. They are invited to contribute self-report outcomes data about their psychological wellbeing, every three months for up to 12 months. Participant groups includes a no-treatment group, and a group that is invited to participate in the ACT intervention (9 short weekly sessions delivered by zoom). Stroke survivors attending intervention groups will be asked to complete additional self-report outcomes data in weeks 1 and weeks 9 of the groups.

• Work package 3 (process evaluation; runs in parallel with pilot trial): observation and filming of intervention group will facilitate monitoring of fidelity, as well as provide opportunities for paraprofessional facilitators to reflect on delivery and competency during ongoing clinical supervision. In addition, the acceptability of course content to stroke survivor attendees will be explored through postal or online feedback questionnaires and qualitative interviews.

Participants. Up to 10 professionals (Stroke Association Coordinators) with some experience of supporting stroke survivors and facilitating groups will be recruited for training in Work Package 1 and subsequent facilitation of groups. Professionals will be recruited from sites across England. For Work packages 2 and 3: up to 30 stroke survivors who are at least four months post-stroke and experiencing difficulties with adjustment and psychological distress will be recruited across the UK using a variety of methods to explore optimal recruitment routes over a 6 month period.

The study is underpinned by United Kingdom Medical Research Council (MRC) updated guidance on developing and evaluating complex interventions. MRC advises that feasibility work can uncover and explore problems of acceptability, compliance, delivery, recruitment and retention; and they recommend that process evaluations are embedded to increase understanding of the intervention and optimise its design and evaluation. At the feasibility stage, process evaluation is an active and iterative process, and changes can and should be made and acted upon while the trial is on-going. As such, the methodological principles are outlined in this record, but it is likely that some specifics may be adjusted as data are collected and learning is implemented.

All data (including recordings) will be handled in line with University of Manchester approved protocols and Study-specific Data Management Plan to ensure the safety and security of data.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: May 1, 2023
• Est. primary completion date: March 15, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion / Exclusion Criteria:

1. Adults in the UK (at least 18 years old)

2. At least 4 months post-stroke (no upper limit);

3. Who identify as having unmet needs in terms of psychological adjustment to stroke and psychological distress. Since exploring eligibility criteria is an aim of this feasibility study, self-report of these symptoms will be sufficient for inclusion. Participants who identify as severely anxious or depressed (or at risk of harm) are likely to be excluded from this research, with information on referral to more appropriate expert psychological support will be provided.

4. Sufficient English language to engage in groups / complete measures

5. Ability to engage in remote group interventions. The groups will be designed to include those who have traditionally been excluded from work like this e.g. those with cognitive and/or communicative difficulties. However, it is important to highlight that this is not an intervention designed for severe issues in these areas. We will aim to include all participants who self-report a willingness and ability to engage in the research, using the required technologies.

Ultimately, we aim to be as inclusive as possible for this study as there are many novel components of the research that we are exploring in terms of feasibility and acceptability. The data collected during the feasibility study describing sample characteristics, acceptability and outcomes may inform formal cut offs to be used in an eventual phase III RCT.

Related Conditions & MeSH terms

• Cognitive Dysfunction
• Communication Disorders
• Psychological Adjustment
• Psychological Distress
• Stroke

Intervention

Other:
• Acceptance and Commitment Therapy
9 x two hour remote sessions (50 minutes activity + 20 minute break + 50 minutes activity). Acceptance and Commitment Therapy (ACT) is a third wave transdiagnostic cognitive-behavioural therapy that supports clients to adjust to current experiences and 'commit' to behaviours that are congruent with their personal values, in order to promote psychological well-being and prevent future mental health crisis. ACT uses a variety of experiential techniques to support this process including: mindfulness practices; exercises to identify personal values; commitment to goals for valued living.

Locations

Country	Name	City	State
United Kingdom	University of Manchester	Manchester

Sponsors (2)

Lead Sponsor	Collaborator
University of Manchester	The Stroke Association, United Kingdom

Country where clinical trial is conducted

United Kingdom, 

References & Publications (1)

Patchwood E, Foote H, Vail A, Cotterill S, Hill G; WAterS PCPI Group; Bowen A. Wellbeing After Stroke (WAterS): Feasibility Testing of a Co-developed Acceptance and Commitment Therapy Intervention to Support Psychological Adjustment After Stroke. Clin Reh — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	modified Barthel Index (self-report)	measure of stroke severity	baseline
Other	Oxford Cognitive Screen (OCS) - Remote	means of describing participants baseline cognitive profile	baseline
Other	Frenchay Aphasia Screening Test (FAST) - remote & Therapy Outcome Measure for Communication Activities	means of describing participants baseline communication profile	baseline
Primary	Study-specific participant qualitative interviews	This is a feasibility and acceptability study so no defined primary outcome (although we are collecting many candidate measures to explore standard deviations and inform primary outcome for any eventual phase III trial).; Participant interviews will help us understand more about acceptability and feasibility, alongside observational data e.g. recruitment rates; retention rates; satisfaction and acceptability; fidelity measures etc.	Following 9 week group support delivery,
Primary	Study-specific participant feedback questionnaire	As above, with all participants being asked to complete feedback questionnaires after groups, even if they do not wish to participate in interviews	Following 9 week group support delivery
Primary	Acceptance and Commitment Therapy Fidelity Measure (ACT-FM)	To help us understand if we can /have achieved fidelity to intervention; a key piece of knowledge that will inform feasibility of a phase III trial. All ACT group sessions will be video recorded with a randomly selected sample reviewed against the ACT-FM.; ACT groups ran in August 2021(max N=2) and October 2021 (max N=2). There are 9 weekly recorded sessions per group, giving a maximum of 36 recorded sessions.	Following 9 week ACT group support delivery
Secondary	Psychological distress at baseline and every 3 months as measured by Clinical Outcomes in Routine Evaluation 10 (CORE-10)	PLEASE NOTE: We are finalising a systematic review and Patient and Carer Collaboration sessions that will determine which of these two tools we use in our research. The final choice will be made based on psychometric credentials as well as consideration of the overall burden of completion of outcome measure surveys.; We are likely to use the Clinical Outcomes in Routine Evaluation 10 (CORE-10), as stated above but are also considering the Depression, Anxiety and Stress Scale - 21 Items (DASS-21)	baseline + every 3 months up to 12 months
Secondary	Mood at baseline and every 3 months as measured by General Health Questionnaire - 12 items (GHQ12)	PLEASE NOTE: We are finalising a systematic review and Patient and Carer Collaboration sessions that will determine which of these two tools we use in our research. The final choice will be made based on psychometric credentials as well as consideration of the overall burden of completion of outcome measure surveys.; We are likely to use the General Health Questionnaire - 12 items (GHQ12), as stated above but are also considering the Hospital Anxiety and Depression Scale (HADS)	baseline + every 3 months up to 12 months
Secondary	Personal wellbeing at baseline and every 3 months as measured by the Office of National Statistics (ONS) four subjective well-being questions (ONS4)	PLEASE NOTE: We are finalising a systematic review and Patient and Carer Collaboration sessions that will determine which of these two tools we use in our research. The final choice will be made based on psychometric credentials as well as consideration of the overall burden of completion of outcome measure surveys.; We are likely to use the Personal Wellbeing Score (PWS) based on the Office of National Statistics (ONS) four subjective well-being questions (ONS4), as stated above but are also considering the Patient-Reported Outcomes Measurement Information System Global 10 (PROMIS-10)	baseline + every 3 months up to 12 months
Secondary	Psychological flexibility at baseline and every 3 months as measured by the Acceptance and. Action Questionnaire - Acquired Brain Injury (AAQ-ABI)	PLEASE NOTE: We are finalising a systematic review and Patient and Carer Collaboration sessions that will determine which of these two tools we use in our research. The final choice will be made based on psychometric credentials as well as consideration of the overall burden of completion of outcome measure surveys.; Psychological flexibility is a concept representing adjustment and acceptance; it is the target process of Acceptance and Commitment Therapy interventions.; We are likely to use the Acceptance and. Action Questionnaire - Acquired Brain Injury (AAQ-ABI), as stated above but are also considering the Acceptance and. Action Questionnaire (AAQ-II).	baseline + every 3 months up to 12 months
Secondary	Valued living measure at baseline and every 3 months as measured by the Valuing Questionnaire (VQ)	PLEASE NOTE: We are finalising a systematic review and Patient and Carer Collaboration sessions that will determine which of these two tools we use in our research. The final choice will be made based on psychometric credentials as well as consideration of the overall burden of completion of outcome measure surveys.; Like psychological flexibility, valued living is another target process measure of Acceptance and Commitment Therapy.	baseline + every 3 months up to 12 months

External Links

•   Dr Emma Patchwood (Chief Investigator) Research profile
•   YouTube channel where interested parties can listen to and read a lay-friendly report on study findings